Less frequent Copaxone

The FDA, the American drug regulator, has approved a new dose of glatiramer acetate (Copaxone) that is injected three times a week rather than daily (both versions will be available) . Teva press release Glatiramer acetate (Copaxone) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news